US Business
Google Signs Deal to Buy Fusion Energy From Bill Gates-Backed Nuclear Startup
The tech giant is betting that Commonwealth Fusion Systems could start producing fusion power next decade.
Articles by Erin Slifka
Health Care
Freeman Health System Celebrates Newest Pharmacy Residency Graduation
(Joplin, MO) – Three years of intense learning condensed into a single year’s time — that’s how Andy Shi, Freeman Health System’s PGY1 (postgraduate year one) pharmacy residency program’s newest graduate — describes life over […]
Entertainment
Nexus, an OCH Event Center to Host Sushi-Making Class on July 12
(Webb City, MO) – Ozarks Community Hospital (OCH) invites culinary enthusiasts and adventurous foodies to beat the summer heat with a unique and refreshing experience: a hands-on Sushi-Making Class on Saturday, July 12, 2025, from […]
US Business
Trump Wants to Expand Nuclear Power. It Won’t Be Easy.
Developers need to prove they can deliver on time and on budget to kick-start interest.
US Business
Avadel Shareholder Seeks Ousting Drugmaker’s Entire Board
ASL Strategic Value Fund wants the narcolepsy drugmaker to retain investment bankers and consider a sale.
US Business
Delta Air Lines Works to Recover After Storms Snarl Weekend Travel
Rough weather struck the carrier’s Atlanta hub. Airlines have canceled more than 2,800 U.S. flights since Friday.
US Business
One American’s Two-Year Quest to Move His Business Out of China
President Trump’s first-term tariffs were a wake-up call for Ryan Bursky’s company. Now, he is working with his Chinese suppliers to move everything to Cambodia.
US Business
Wall Street Hangs On to Hopes for a Boom in Deals
Blockbuster tie-ups continued in the second quarter in industries relatively insulated from tariffs.
US Business
Your Next Cruise to Mexico Could Cost More. Here’s Why.
A new passenger tax goes into effect on July 1 as the government negotiates with Royal Caribbean and other companies.
US Business
CoreWeave in Talks to Buy Core Scientific
CoreWeave last year tried to acquire Core Scientific for $5.75 a share, which at the time valued the business at north of $1 billion. Core Scientific rejected the proposal as too low.